The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The therapeutic strategy for choosing lenvatinib in systemic therapy for unresectable hepatocellular carcinoma.
 
Kaoru Tsuchiya
Speakers' Bureau - Bayer; Chugai/Roche; Eisai; Lilly Japan; Takeda
 
Masayuki Kurosaki
Speakers' Bureau - Bayer; Chugai/Roche; Eisai; Lilly Japan; Takeda
 
Yutaka Yasui
No Relationships to Disclose
 
Shun Kaneko
No Relationships to Disclose
 
Sakura Kirino
No Relationships to Disclose
 
Kento Inada
No Relationships to Disclose
 
Yuki Tanaka
No Relationships to Disclose
 
Shun Ishido
No Relationships to Disclose
 
Koji Yamashita
No Relationships to Disclose
 
Tsubasa Nobusawa
No Relationships to Disclose
 
Yuka Hayakawa
No Relationships to Disclose
 
Hiroaki Matsumoto
No Relationships to Disclose
 
Tatsuya Kakegawa
No Relationships to Disclose
 
Mayu Higuchi
No Relationships to Disclose
 
Kenta Takaura
No Relationships to Disclose
 
Shohei Tanaka
No Relationships to Disclose
 
Chiaki Maeyashiki
No Relationships to Disclose
 
Nobuharu Tamaki
No Relationships to Disclose
 
Hiroyuki Nakanishi
No Relationships to Disclose
 
Namiki Izumi
Speakers' Bureau - Bayer; Chugai/Roche; Eisai; Lilly Japan; Takeda